Aviva’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,194
Closed -$617K 874
2025
Q4
$617K Sell
13,194
-88
-0.7% -$3.81K ﹤0.01% 686
2025
Q3
$556K Buy
13,282
+813
+7% +$35.7K ﹤0.01% 689
2025
Q2
$549K Buy
+12,469
New +$565K ﹤0.01% 691
2023
Q4
Sell
-16,209
Closed -$587K 982
2023
Q3
$587K Sell
16,209
-20,730
-56% -$770K ﹤0.01% 799
2023
Q2
$1.39M Buy
36,939
+5,621
+18% +$226K 0.01% 766
2023
Q1
$1.45M Buy
31,318
+8,723
+39% +$407K 0.01% 775
2022
Q4
$1.05M Sell
22,595
-12,108
-35% -$551K 0.01% 788
2022
Q3
$1.52M Sell
34,703
-11,826
-25% -$544K 0.01% 780
2022
Q2
$1.97M Sell
46,529
-4,460
-9% -$189K 0.01% 826
2022
Q1
$2.22M Buy
+50,989
New +$2.36M 0.01% 800
2020
Q1
Sell
-46,339
Closed -$1.95M 956
2019
Q4
$1.95M Buy
+46,339
New +$1.85M 0.01% 740

Other funds holding G

Aviva's G Position: Q1 2026 in Review

Aviva sold out of Genpact (G) in Q1 2026, closing a stake of 13,194 shares — an estimated $617K sold.

Aviva first reported a position in G in Q4 2019 and held it in 11 quarters. The position peaked at $2.22M in Q1 2022. 520 funds tracked by Wall St. Rank hold G as of Q1 2026.

  • Aviva reported no remaining Genpact position as of Q1 2026 after selling out during the quarter.
  • Aviva sold 13,194 Genpact shares in Q1 2026, an estimated $617K.
  • Aviva first reported a position in Genpact in Q4 2019 and held it in 11 quarters.
  • Aviva's Genpact position peaked at $2.22M in Q1 2022.
  • 520 funds tracked by Wall St. Rank held Genpact as of Q1 2026.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.